XML 87 R51.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
EARNINGS (LOSS) PER SHARE (Details) - USD ($)
$ / shares in Units, shares in Millions, $ in Millions
3 Months Ended 12 Months Ended
Dec. 31, 2019
Sep. 30, 2019
Jun. 30, 2019
Mar. 31, 2019
Dec. 31, 2018
Sep. 30, 2018
Jun. 30, 2018
Mar. 31, 2018
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Earnings Per Share, Basic and Diluted [Abstract]                      
Income from continuing operations                 $ 838 $ 736 $ 772
Income from discontinued operations, net of taxes                 20 0 0
Net income attributable to Quest Diagnostics $ 253 $ 215 $ 226 $ 164 $ 127 $ 213 $ 219 $ 177 858 736 772
Less: Earnings allocated to participating securities                 3 3 3
Earnings available to Quest Diagnostics’ common stockholders – basic and diluted                 $ 835    
Earnings available to Quest Diagnostics' common stockholders - basic and diluted                   $ 733 $ 769
Weighted average common shares outstanding - basic                 134 136 137
Stock options and performance share units                 2 3 3
Weighted average common shares outstanding - diluted                 136 139 140
Income from continuing operations (in dollars per share) $ 1.88 $ 1.59 $ 1.52 $ 1.22 $ 0.93 $ 1.56 $ 1.60 $ 1.30 $ 6.21 $ 5.39 $ 5.63
Income from discontinued operations (in dollars per share) 0 0 0.15 0 0 0 0 0 0.15 0 0
Net income (in dollars per share) 1.88 1.59 1.67 1.22 0.93 1.56 1.60 1.30 6.36 5.39 5.63
Income from continuing operations (in dollars per share) 1.86 1.56 1.51 1.20 0.92 1.53 1.57 1.27 6.13 5.29 5.50
Income from discontinued operations (in dollars per share) 0 0 0.15 0 0 0 0 0 0.15 0 0
Net income (in dollars per share) $ 1.86 $ 1.56 $ 1.66 $ 1.20 $ 0.92 $ 1.53 $ 1.57 $ 1.27 $ 6.28 $ 5.29 $ 5.50
Stock options and performance share units not included due to their antidilutive effect                 3 2 2